US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 21.970
  • -0.410-1.83%
Close May 9 16:00 ET
  • 21.970
  • 0.0000.00%
Post 16:20 ET
1.87BMarket Cap-6780P/E (TTM)

Syndax Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-112.98%-83.55M
-20.14%-160.6M
-80.61%-41.35M
-56.44%-44.65M
12.24%-35.37M
6.45%-39.23M
-558.88%-133.68M
-122.73%-22.89M
-14.43%-28.54M
-67.63%-40.31M
Net income from continuing operations
-76.04%-72.4M
-40.19%-209.36M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-699.13%-149.34M
-140.74%-39.19M
-71.53%-35.4M
-64.00%-37.57M
Operating gains losses
----
----
----
----
----
----
51.93%-187K
--0
--0
--0
Depreciation and amortization
0.00%3K
-63.64%12K
0.00%3K
-62.50%3K
-72.73%3K
-72.73%3K
-23.26%33K
-70.00%3K
0.00%8K
22.22%11K
Other non cash items
121.82%244K
-51.51%739K
116.96%243K
-73.43%237K
-42.25%149K
-58.02%110K
714.97%1.52M
123.73%112K
291.23%892K
19.44%258K
Change In working capital
-3,289.51%-16.47M
1,823.91%31.86M
86.20%26.01M
-39.60%1.59M
171.10%4.75M
94.13%-486K
117.26%1.66M
1,006.89%13.97M
132.54%2.63M
-39.42%-6.67M
-Change in receivables
---6.07M
----
----
-145.53%-3.9M
157.98%3.97M
--0
----
----
--8.56M
---6.84M
-Change in prepaid assets
-198.45%-2.85M
122.75%676K
-15.84%3.96M
-36.30%-3.74M
-169.69%-2.44M
134.39%2.9M
-113.20%-2.97M
6,006.49%4.7M
-409.71%-2.74M
306.31%3.5M
-Change in payables and accrued expense
-43.79%-7.86M
152.75%20.48M
39.17%11.42M
389.80%9.23M
259.02%5.3M
-185.18%-5.47M
64.34%8.1M
592.15%8.2M
-193.84%-3.19M
-22.94%-3.33M
-Change in other working capital
-84.87%315K
408.18%10.71M
----
----
----
--2.08M
73.55%-3.47M
----
----
----
Cash from discontinued investing activities
Operating cash flow
-112.98%-83.55M
-20.14%-160.6M
-80.61%-41.35M
-56.44%-44.65M
12.24%-35.37M
6.45%-39.23M
-558.88%-133.68M
-122.73%-22.89M
-14.43%-28.54M
-67.63%-40.31M
Investing cash flow
Cash flow from continuing investing activities
-599.12%-99.4M
163.17%117.61M
88.16%-16.29M
689.97%40.08M
247.97%73.91M
143.40%19.92M
-355.53%-186.19M
-129.55%-137.63M
-125.51%-6.79M
-330.39%-49.95M
Net PPE purchase and sale
----
--0
--0
----
----
----
274.42%225K
--0
----
----
Net investment purchase and sale
-599.12%-99.4M
163.09%117.61M
88.16%-16.29M
671.06%40.08M
247.97%73.91M
143.40%19.92M
-357.52%-186.41M
-130.04%-137.63M
-126.35%-7.02M
-330.39%-49.95M
Cash from discontinued investing activities
Investing cash flow
-599.12%-99.4M
163.17%117.61M
88.16%-16.29M
689.97%40.08M
247.97%73.91M
143.40%19.92M
-355.53%-186.19M
-129.55%-137.63M
-125.51%-6.79M
-330.39%-49.95M
Financing cash flow
Cash flow from continuing financing activities
-12.37%2.17M
53.34%264.13M
58.09%258.48M
113.69%1.85M
-93.90%1.32M
344.17%2.47M
45.41%172.25M
48.94%163.5M
-893.26%-13.53M
260.80%21.72M
Net issuance payments of debt
----
--0
--0
----
----
----
---21M
--2K
----
----
Net common stock issuance
----
42.29%258.09M
59.35%258.09M
--0
----
----
110.10%181.39M
99.45%161.96M
--0
----
Proceeds from stock option exercised by employees
-12.37%2.17M
-49.09%6.04M
-74.69%389K
-75.23%1.85M
-42.26%1.32M
344.17%2.47M
-62.41%11.86M
-94.51%1.54M
338.30%7.47M
157.93%2.29M
Cash from discontinued financing activities
Financing cash flow
-12.37%2.17M
53.34%264.13M
58.09%258.48M
113.69%1.85M
-93.90%1.32M
344.17%2.47M
45.41%172.25M
48.94%163.5M
-893.26%-13.53M
260.80%21.72M
Net cash flow
Beginning cash position
296.95%295.61M
-66.47%74.47M
32.56%94.77M
-19.00%97.49M
-69.49%57.63M
-66.47%74.47M
92.51%222.08M
-0.08%71.49M
76.59%120.35M
192.85%188.89M
Current changes in cash
-973.57%-180.78M
249.81%221.14M
6,641.99%200.84M
94.42%-2.73M
158.16%39.86M
49.27%-16.84M
-238.31%-147.61M
-98.02%2.98M
-1,540.51%-48.86M
-1,975.08%-68.53M
End cash Position
99.25%114.83M
296.95%295.61M
296.95%295.61M
32.56%94.77M
-19.00%97.49M
-69.49%57.63M
-66.47%74.47M
-66.47%74.47M
-0.08%71.49M
76.59%120.35M
Free cash flow
-112.98%-83.55M
-20.14%-160.6M
-80.61%-41.35M
-56.44%-44.65M
12.24%-35.37M
6.45%-39.23M
-560.92%-133.68M
-122.76%-22.89M
-14.43%-28.54M
-67.63%-40.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -112.98%-83.55M-20.14%-160.6M-80.61%-41.35M-56.44%-44.65M12.24%-35.37M6.45%-39.23M-558.88%-133.68M-122.73%-22.89M-14.43%-28.54M-67.63%-40.31M
Net income from continuing operations -76.04%-72.4M-40.19%-209.36M-84.91%-72.47M-44.47%-51.15M-18.75%-44.62M-10.65%-41.13M-699.13%-149.34M-140.74%-39.19M-71.53%-35.4M-64.00%-37.57M
Operating gains losses ------------------------51.93%-187K--0--0--0
Depreciation and amortization 0.00%3K-63.64%12K0.00%3K-62.50%3K-72.73%3K-72.73%3K-23.26%33K-70.00%3K0.00%8K22.22%11K
Other non cash items 121.82%244K-51.51%739K116.96%243K-73.43%237K-42.25%149K-58.02%110K714.97%1.52M123.73%112K291.23%892K19.44%258K
Change In working capital -3,289.51%-16.47M1,823.91%31.86M86.20%26.01M-39.60%1.59M171.10%4.75M94.13%-486K117.26%1.66M1,006.89%13.97M132.54%2.63M-39.42%-6.67M
-Change in receivables ---6.07M---------145.53%-3.9M157.98%3.97M--0----------8.56M---6.84M
-Change in prepaid assets -198.45%-2.85M122.75%676K-15.84%3.96M-36.30%-3.74M-169.69%-2.44M134.39%2.9M-113.20%-2.97M6,006.49%4.7M-409.71%-2.74M306.31%3.5M
-Change in payables and accrued expense -43.79%-7.86M152.75%20.48M39.17%11.42M389.80%9.23M259.02%5.3M-185.18%-5.47M64.34%8.1M592.15%8.2M-193.84%-3.19M-22.94%-3.33M
-Change in other working capital -84.87%315K408.18%10.71M--------------2.08M73.55%-3.47M------------
Cash from discontinued investing activities
Operating cash flow -112.98%-83.55M-20.14%-160.6M-80.61%-41.35M-56.44%-44.65M12.24%-35.37M6.45%-39.23M-558.88%-133.68M-122.73%-22.89M-14.43%-28.54M-67.63%-40.31M
Investing cash flow
Cash flow from continuing investing activities -599.12%-99.4M163.17%117.61M88.16%-16.29M689.97%40.08M247.97%73.91M143.40%19.92M-355.53%-186.19M-129.55%-137.63M-125.51%-6.79M-330.39%-49.95M
Net PPE purchase and sale ------0--0------------274.42%225K--0--------
Net investment purchase and sale -599.12%-99.4M163.09%117.61M88.16%-16.29M671.06%40.08M247.97%73.91M143.40%19.92M-357.52%-186.41M-130.04%-137.63M-126.35%-7.02M-330.39%-49.95M
Cash from discontinued investing activities
Investing cash flow -599.12%-99.4M163.17%117.61M88.16%-16.29M689.97%40.08M247.97%73.91M143.40%19.92M-355.53%-186.19M-129.55%-137.63M-125.51%-6.79M-330.39%-49.95M
Financing cash flow
Cash flow from continuing financing activities -12.37%2.17M53.34%264.13M58.09%258.48M113.69%1.85M-93.90%1.32M344.17%2.47M45.41%172.25M48.94%163.5M-893.26%-13.53M260.80%21.72M
Net issuance payments of debt ------0--0---------------21M--2K--------
Net common stock issuance ----42.29%258.09M59.35%258.09M--0--------110.10%181.39M99.45%161.96M--0----
Proceeds from stock option exercised by employees -12.37%2.17M-49.09%6.04M-74.69%389K-75.23%1.85M-42.26%1.32M344.17%2.47M-62.41%11.86M-94.51%1.54M338.30%7.47M157.93%2.29M
Cash from discontinued financing activities
Financing cash flow -12.37%2.17M53.34%264.13M58.09%258.48M113.69%1.85M-93.90%1.32M344.17%2.47M45.41%172.25M48.94%163.5M-893.26%-13.53M260.80%21.72M
Net cash flow
Beginning cash position 296.95%295.61M-66.47%74.47M32.56%94.77M-19.00%97.49M-69.49%57.63M-66.47%74.47M92.51%222.08M-0.08%71.49M76.59%120.35M192.85%188.89M
Current changes in cash -973.57%-180.78M249.81%221.14M6,641.99%200.84M94.42%-2.73M158.16%39.86M49.27%-16.84M-238.31%-147.61M-98.02%2.98M-1,540.51%-48.86M-1,975.08%-68.53M
End cash Position 99.25%114.83M296.95%295.61M296.95%295.61M32.56%94.77M-19.00%97.49M-69.49%57.63M-66.47%74.47M-66.47%74.47M-0.08%71.49M76.59%120.35M
Free cash flow -112.98%-83.55M-20.14%-160.6M-80.61%-41.35M-56.44%-44.65M12.24%-35.37M6.45%-39.23M-560.92%-133.68M-122.76%-22.89M-14.43%-28.54M-67.63%-40.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg